GSK
Desconocido
ADAPT: Adipokines as Drug Targets to Combat Adverse Effects of Excess Adipose Tissue
LABORATOIRE GLAXOSMITHKLINE
participó en un
FP7:
Obesity represents the major risk factor for the cardiometabolic syndrome, which is an epidemic disease that generates a severe global socio...
Financiado
Financiado
* No se disponen de datos de la empresa actual.